Muscarinic receptor agonists and antagonists
- 1 August 1999
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 9 (8) , 1029-1053
- https://doi.org/10.1517/13543776.9.8.1029
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- IN VITRO CHARACTERIZATION OF A NOVEL, POTENT AND SELECTIVE M3 ANTAGONISTLife Sciences, 1997
- Synthesis and Biological Characterization of 1,4,5,6-Tetrahydropyrimidine and 2-Amino-3,4,5,6-tetrahydropyridine Derivatives as Selective m1 AgonistsJournal of Medicinal Chemistry, 1997
- Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypesLife Sciences, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- Design, synthesis and biological activity of some 4-DAMP- related compoundsBioorganic & Medicinal Chemistry Letters, 1995
- Synthesis and biological activity of enantiomers of a conformationally restricted muscarone analogBioorganic & Medicinal Chemistry Letters, 1995
- Allosteric modulation of muscarinic acetylcholine receptorsTrends in Pharmacological Sciences, 1995
- Design, synthesis and biological activity of some tetraamines related to methoctramine and 4-DAMPBioorganic & Medicinal Chemistry Letters, 1995
- Regioisomeric 3-, 4- and 5-aminomethyl isoxazoles: synthesis and muscarinic activityEuropean Journal of Medicinal Chemistry, 1995
- Therapeutic potential of CNS-active M2 antagonists: Novel structures and pharmacologyLife Sciences, 1993